Skip to main content
Enter the terms you wish to search for.
Select Search Option
This Site
All WCM Sites
Directory
Menu
Weill Cornell Medicine
Care
Discover
Teach
Beltran Lab
Explore this Website
Home
About Us
Toggle About Us menu options
Contact Us
Job Opportunities
Videos
Affiliations
Research
Lab Team
News
Publications
Weill Cornell Medicine
Care
Discover
Teach
Home
About Us
Affiliations
Research
Lab Team
News
Publications
Home
Publications
Publications
Found 7 results
Author
Title
Type
Year
Filters:
Author
is
Fazli, Ladan
[Clear All Filters]
2018
Chedgy ECp
,
Vandekerkhove G
,
Herberts C
,
Annala M
,
Donoghue AJ
,
Sigouros M
,
Ritch E
,
Struss W
,
Konomura S
,
Liew J
et al.
. 2018.
Biallelic tumor suppressor loss and DNA repair defects in de novo small cell prostate cancer.
.
J Pathol.
2017
Beltran H
,
Wyatt AW
,
Chedgy E
,
Donoghue A
,
Annala M
,
Warner E
,
Beja K
,
Sigouros M
,
Mo F
,
Fazli L
et al.
. 2017.
Impact of therapy on genomics and transcriptomics in high-risk prostate cancer treated with neoadjuvant docetaxel and androgen deprivation therapy.
.
Clin Cancer Res.
Bishop JL
,
Thaper D
,
Vahid S
,
Davies A
,
Ketola K
,
Kuruma H
,
Jama R
,
Nip KMun
,
Angeles A
,
Johnson F
et al.
. 2017.
The Master Neural Transcription Factor BRN2 Is an Androgen Receptor-Suppressed Driver of Neuroendocrine Differentiation in Prostate Cancer.
.
Cancer Discov. 7(1):54-71.
2015
Akamatsu S
,
Wyatt AW
,
Lin D
,
Lysakowski S
,
Zhang F
,
Kim S
,
Tse C
,
Wang K
,
Mo F
,
Haegert A
et al.
. 2015.
The Placental Gene PEG10 Promotes Progression of Neuroendocrine Prostate Cancer.
.
Cell Rep. 12(6):922-36.
2014
Lin D
,
Wyatt AW
,
Xue H
,
Wang Y
,
Dong X
,
Haegert A
,
Wu R
,
Brahmbhatt S
,
Mo F
,
Jong L
et al.
. 2014.
High fidelity patient-derived xenografts for accelerating prostate cancer discovery and drug development.
.
Cancer Res. 74(4):1272-83.
2012
Lapuk AV
,
Wu C
,
Wyatt AW
,
McPherson A
,
McConeghy BJ
,
Brahmbhatt S
,
Mo F
,
Zoubeidi A
,
Anderson S
,
Bell RH
et al.
. 2012.
From sequence to molecular pathology, and a mechanism driving the neuroendocrine phenotype in prostate cancer.
.
J Pathol. 227(3):286-97.
Collins CC
,
Volik SV
,
Lapuk AV
,
Wang Y
,
Gout PW
,
Wu C
,
Xue H
,
Cheng H
,
Haegert A
,
Bell RH
et al.
. 2012.
Next generation sequencing of prostate cancer from a patient identifies a deficiency of methylthioadenosine phosphorylase, an exploitable tumor target.
.
Mol Cancer Ther. 11(3):775-83.